{"name":"Ochsner Health System","slug":"ochsner-health-system","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Furosemide plus Chlorothiazide","genericName":"Furosemide plus Chlorothiazide","slug":"furosemide-plus-chlorothiazide","indication":"Edema and fluid overload in heart failure, renal disease, or hepatic cirrhosis","status":"marketed"},{"name":"Slow Infusion of Rubidium-82","genericName":"Slow Infusion of Rubidium-82","slug":"slow-infusion-of-rubidium-82","indication":"Myocardial perfusion imaging for detection of coronary artery disease","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Ambrisentan Pill","genericName":"Ambrisentan Pill","slug":"ambrisentan-pill","indication":"Other","status":"marketed"},{"name":"intravenous NAC","genericName":"intravenous NAC","slug":"intravenous-nac","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"HyperAcute vaccine","genericName":"HyperAcute vaccine","slug":"hyperacute-vaccine","indication":"COVID-19 prevention","status":"phase_2"}]}],"pipeline":[{"name":"Furosemide plus Chlorothiazide","genericName":"Furosemide plus Chlorothiazide","slug":"furosemide-plus-chlorothiazide","phase":"marketed","mechanism":"This combination of two loop and thiazide diuretics works by inhibiting sodium and chloride reabsorption in the kidney to increase urine output and reduce fluid overload.","indications":["Edema and fluid overload in heart failure, renal disease, or hepatic cirrhosis","Resistant hypertension"],"catalyst":""},{"name":"Slow Infusion of Rubidium-82","genericName":"Slow Infusion of Rubidium-82","slug":"slow-infusion-of-rubidium-82","phase":"marketed","mechanism":"Rubidium-82 is a positron-emitting radioactive tracer that accumulates in myocardial tissue proportional to blood flow, allowing visualization of cardiac perfusion defects via PET imaging.","indications":["Myocardial perfusion imaging for detection of coronary artery disease","Assessment of myocardial viability in patients with coronary artery disease"],"catalyst":""},{"name":"Ambrisentan Pill","genericName":"Ambrisentan Pill","slug":"ambrisentan-pill","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HyperAcute vaccine","genericName":"HyperAcute vaccine","slug":"hyperacute-vaccine","phase":"phase_2","mechanism":"The HyperAcute vaccine works by stimulating the body's immune system to recognize and fight specific diseases.","indications":["COVID-19 prevention"],"catalyst":""},{"name":"intravenous NAC","genericName":"intravenous NAC","slug":"intravenous-nac","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOM1ZfMV9hQUx2c0M4bHJCOWNRWkpfVDRpV2EybEhpMjVOaW4zdV8yQzNrSFZacVFndnBmRmQ1X3A3QXgtbm10NU42bFhlR3l6Q1plVWdJVmJhZmZJYVZnZjBpeUkxdEo0UnAwS0IyY0JzbncyTHJ5NFROYUJMaTRQWEVacHhzODdOR3o1SEJwTTdSV0k1M0RuVzNlOUZhYkFGaVE?oc=5","date":"2026-03-26","type":"deal","source":"Pharmaceutical Technology","summary":"Cognito Therapeutics and Ochsner partner for new brain health approaches - Pharmaceutical Technology","headline":"Cognito Therapeutics and Ochsner partner for new brain health approaches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNUUMwTG03aUxvd3dCNzg0OTE5Wkc5cm9SVVVDaEtrYnhtVWM0Q3pveW8ybGlURjBxc3Q2cG9qR1c4RXhTLWhkYmpwaFdRVFp0UFdmWmtraFRKLXpSZXBzeTlRME1KVXdqblZ3TFBrWXhPSGtOUS1QYlNTWUV6OFZObDB2YmhYYWppYzU3U0JXa3VmcWRMY2NtQUl6SXZCN2pSRXU0bFdqUzRzUDhiNm5zVEMtR2Y3NlIwUWJlNGFEZy1sZDJWbzRQTURDN0dPdFNvYVdhMUJYT19jMHd4STN6ZnJxSWtGQWpZYkVrOV9sTzRsNUR0SHc?oc=5","date":"2026-02-18","type":"deal","source":"KTBS 3","summary":"Starget Pharma secures $18M, launches cancer therapy collaboration in Shreveport - KTBS 3","headline":"Starget Pharma secures $18M, launches cancer therapy collaboration in Shreveport - KTBS 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1KM19JWE1qY3VpWXB5SUtteGJrYS11RFQyLVpmOG9MdllHeFMtWXZFc2E1QW5LWGk1X2pISGQtbXo1aTN1YlFnNENENUhfLWVvSUFXTDNxQV95eUJtMTBXM3pXd1VJYy13TV9CRUxnRTBOVXgzWXlDcFJLc04wUQ?oc=5","date":"2025-12-18","type":"pipeline","source":"fiercehealthcare.com","summary":"Chutes & Ladders—Humana CEO named AHIP board chair; FAH taps new CEO - fiercehealthcare.com","headline":"Chutes & Ladders—Humana CEO named AHIP board chair; FAH taps new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPVXYycDk5LWtpNnRGVGNCelB2WkQ3M2VLWWdialZ4YWFUMVVqendweU13WnpadmYwQXlTSThwLXNlbUUtMVItM2llZ0VyVG8wY0tXM1o0MUNOTUJuTVU2QzR4WlNkak5TaUx4eU9HMV9hdXV2QzRyY3RnUjl2VGoycDJhVFJ4NG1qc0lXcmZVOVFmVkk5WV9CVklIdmJFSjJMUmNmVUZNaXd0MWVxX0o2TU9JZVlWR0k?oc=5","date":"2025-09-03","type":"pipeline","source":"Fierce Pharma","summary":"BD re-ups 'Love Your Limbs' campaign to boost peripheral artery disease diagnosis - Fierce Pharma","headline":"BD re-ups 'Love Your Limbs' campaign to boost peripheral artery disease diagnosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQSzUzb2hyMlJZVkM3RDMxeFU3amk2SE9MYUdDTXAyUU0weDRUcVpyb0lNUTFmT2dXdmhYcm80YVQzWmtsb1M0cXVCbHkwbDViVzA3RWVwdGFhd3N6ZHdpSE4tR3lqRy1Vd1Z2cGZKbzRQR3BHVWU3NGtaOXhHWll3RFhOcE05Q296WGxmdTdtZnRDOFBXUnRhc21QYmZOSGVZUDNIcVNUbElLQkVobG9xRWJGZE52U09CajRMWXI0V1F6eknSAcgBQVVfeXFMTUo0T0JCemh3eXRaZXBFeGlWcnF4c05seS1TQUFsUVFQV1E0QUJZNjhrWEZxTWlET3dYVUI3eG1yZTg1SktldTZQTk1YZC1LTDNoRGZiSGRPSnNXRkRUbzBYSnlVZG9GdV8xcldscXlNNUtpeTAxUy1NcGVuSUtvWHI1akJuVWh6VXMwSXhQQXEzNUp0aEFsRU93cTBQZnExNnhUV29TOWh4bVR0QmlqcmJpV0c3d05XVXU0cU04QlRIMHBGRkxMbmg?oc=5","date":"2025-08-30","type":"pipeline","source":"NOLA.com","summary":"On the front lines of health care, this Louisiana pharmacist fell in love with science and service - NOLA.com","headline":"On the front lines of health care, this Louisiana pharmacist fell in love with science and service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPV0xtZ05ZNFFlYmJzQUdXLS1kZzNFUUZIMUtXdF9qVmZBWnFZTmxqMVV4MDI2SkFYV3BnTEVhWXFjTGNRanI1TWlBR2lialJDQUxEQm1QamxMb1cxR2t6RFJ0NXR0aHlKLVpWVGJ3SVZ2ZHlwTUQ0QmxkSGR5V0gtNWhLQ3B4WUJZSC1nVnMwbGpPMG5GbzZQaWNGUEc?oc=5","date":"2025-07-25","type":"pipeline","source":"Pharmacy Times","summary":"Transforming Pharmacy Operations at Ochsner Health Through AI - Pharmacy Times","headline":"Transforming Pharmacy Operations at Ochsner Health Through AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5OT21EZDI0ek1UNEotVndMVDFGLVJDanFNLTFKNTZPWkNtTWN1X1hIMVNZdEJOR29DOFhaYlZETFJsSkpia1N3dTM5S1VEZm1MaWNMTjV1aVBJQU1janBqeDhXVmNuTkNRVUJnSmUzNlQ?oc=5","date":"2025-07-01","type":"pipeline","source":"MedCity News","summary":"Ochsner Health Scales AI Tool After Its Cuts Prior Authorization Time to Just 4-5 Minutes - MedCity News","headline":"Ochsner Health Scales AI Tool After Its Cuts Prior Authorization Time to Just 4-5 Minutes","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-16","type":"deal","source":"Newswise","summary":"Ochsner Health Partners with Latent Health to Accelerate AI-Driven Medication Access | Newswise - Newswise","headline":"Ochsner Health Partners with Latent Health to Accelerate AI-Driven Medication Access | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQQlBCeHJYSnhnaTcwaWxfS3Uwak42aFkxR1ZmcF92TElLUkVueVIyMDJyajdkWUtSQklaQm5pcVF4MlFhWGxFN2U4ZVE1NUFIbjZUMklJQ0RFb2oyRl9JOU82ZWo3WHp0YWZFWlNhXzVmQnhxNlJ3NGk2dmVIcFg3OGQ3ZlhmQjhiUmhvcjFCc2VuMFF3M01aazJOOEdfZjJK?oc=5","date":"2025-06-02","type":"pipeline","source":"Medical Xpress","summary":"Pharmacogenomics offers roadmap for integrating genetics into personalized medicine - Medical Xpress","headline":"Pharmacogenomics offers roadmap for integrating genetics into personalized medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPTXY4Sk5rTDk5ZVEyMlh6N3dxTGNhdlY5NEJMOEhLVVltTWpYU0F6bHFWQWFnaVVJUm9FSlItaEV3OWNoZExLV01oMV9WNmFlRi15eW9qVHhTMlZZdUFrS2NGbEU0RUtwaXY0eXRoS1B5TFU5Z2Q2QVF6Q0dMNFVQTzhQVVVaUHdZMmFMLTk3UW1hZEpBNUV4NmNRNFBWX0U?oc=5","date":"2025-05-21","type":"pipeline","source":"New Orleans CityBusiness","summary":"New Orleans biotech advances non-opioid pain drug - New Orleans CityBusiness","headline":"New Orleans biotech advances non-opioid pain drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOb3hDeWJfbEh2cDI5al9JejFielgxbTM4QTI0Ujhhem9ucVpMcVQ3dk1NeFJOQ0I2NmZJZzVJWC1ZM2xfYXRUTlBCQ1BmZUhPQXdWckNwXzk4OXhSVWYxR2Y4ZFI3Q01xZldxd1d1SGIwNkhoNks1a2VEak5yaVRVbGRZODNsd2J4S1pUYko1cHU2ZjBLNHo5TVdUMVF0akJwSW9FaF9ETGFxem1LZEk2ckVyTkhjRXpzWjFGMUVsQ3FIVTFUVVF1cjdMWUNYeVYzOFJvSmhITTBPME9ibjlKVA?oc=5","date":"2025-04-10","type":"pipeline","source":"PR Newswire","summary":"South Rampart Pharma Strengthens Board with Appointment of Ochsner Health CEO Pete November - PR Newswire","headline":"South Rampart Pharma Strengthens Board with Appointment of Ochsner Health CEO Pete November","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOVFdkZERlRGhsOHlsN1NhdC1Ubk4weWVHcnpHdkJwNU92UHh1NVNCRVFBNE1maTZ2Y2xhckpPOUpWQ0JrNTlNQVRzUVM5bHZfVTgwaVN3NXplbzE3bFBvZkkwLWdFVVZYWWdMc1dIVGEtbnBpMXUxSmxPazVrMzJ6M1NvOWRDZXpOYzRXVko4SV9GMFNWWDBQUm1qckxJVDFkalVWUGJjbjgwbE9XcjctOWpSYw?oc=5","date":"2024-08-12","type":"pipeline","source":"American Medical Association","summary":"Ochsner Health sees big return on investment in remote care - American Medical Association","headline":"Ochsner Health sees big return on investment in remote care","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":4,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}